Charming Medical Ltd. Faces Class Action Lawsuit Over Alleged Securities Fraud
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 10h ago
0mins
Source: Globenewswire
- Class Action Filed: Pomerantz LLP has initiated a class action lawsuit against Charming Medical Ltd., alleging securities fraud by the company and certain officers, with investors needing to apply as Lead Plaintiff by February 17, 2026.
- Stock Price Fluctuation: On November 11, 2025, Charming's stock closed at $29.36, reaching an intraday high of $31.70, with a market capitalization of approximately $504 million, indicating significant market interest.
- SEC Trading Halt: The U.S. Securities and Exchange Commission halted trading of Charming securities from November 12 to 25, 2025, due to reports of scammers artificially inflating stock prices through social media manipulation.
- Allegations of Manipulation: Public reports have alleged that Charming's stock was a primary vehicle for an illicit
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
